News
Blue Cross Blue Shield of Massachusetts says it will soon stop covering popular drugs for weight loss, like Ozempic and ...
Two common GLP-1 medications that are approved by the Food and Drug Administration (FDA) specifically for weight loss are ...
In the long term, bariatric surgery is more cost-effective than new anti-obesity medications, research finds, triggering a ...
Massachusetts' largest commercial health insurer is rolling back its coverage of GLP-1 drugs like Ozempic and Wegovy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results